114 related articles for article (PubMed ID: 7825420)
1. Efficacy and safety of timolol/pilocarpine combination drops in glaucoma patients.
Uusitalo RJ; Palkama A
Acta Ophthalmol (Copenh); 1994 Aug; 72(4):496-504. PubMed ID: 7825420
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Nordmann JP; Söderström M; Rouland JF; Malecaze F
Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
[TBL] [Abstract][Full Text] [Related]
3. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
4. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
[TBL] [Abstract][Full Text] [Related]
5. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
[TBL] [Abstract][Full Text] [Related]
6. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group.
Puustjärvi TJ; Repo LP
Arch Ophthalmol; 1992 Dec; 110(12):1725-9. PubMed ID: 1342582
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
8. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
9. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Adamsons IA; Polis A; Ostrov CS; Boyle JE
J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
[TBL] [Abstract][Full Text] [Related]
10. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
Leroy C; Collignon-Brach J
J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
Brandt JD; VanDenburgh AM; Chen K; Whitcup SM;
Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
[TBL] [Abstract][Full Text] [Related]
13. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
14. Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech J; Stewart WC
Am J Ophthalmol; 2003 Feb; 135(2):138-43. PubMed ID: 12566015
[TBL] [Abstract][Full Text] [Related]
15. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
[TBL] [Abstract][Full Text] [Related]
16. [Experiences in a double-blind study with different concentrations of timolol and pilocarpine (author's transl)].
Merté HJ; Merkle W
Klin Monbl Augenheilkd; 1980 Oct; 177(4):443-50. PubMed ID: 7019558
[TBL] [Abstract][Full Text] [Related]
17. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
Strohmaier K; Snyder E; Adamsons I
J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
[TBL] [Abstract][Full Text] [Related]
19. Timolol in maintenance treatment of ocular hypertension and glaucoma.
Nielsen NV; Eriksen JS
Acta Ophthalmol (Copenh); 1979; 57(6):1070-7. PubMed ID: 546004
[TBL] [Abstract][Full Text] [Related]
20. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
